270.24 USD
↗ 2.87 (1.07%)AT CLOSE (11:59 AM EDT)
Johnson & Johnson
JNJNYSE • USD
270.50
↗ 0.26 (0.10%)
POST MARKET (AS OF 05:46 PM EDT)
Post Market
AS OF 05:46 PM EDT
270.50
↗ 0.26 (0.10%)
Market: OPEN
Johnson & Johnson (JNJ) trades at $270.50 per share. Technical and fundamental signals align bullish — technicals rate "Strong Buy" while fundamentals indicate "Buy". This is driven by a robust Altman Z-Score, exceptional Return on Equity (24.8%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, JNJ trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 21, 2026.
Open?$267.83
High?$272.66
Low?$267.00
Prev. Close?$267.37
Volume?6.2M
Avg. Volume?7.5M
VWAP?$270.21
Rel. Volume?0.82x
Bid / Ask
Bid?$270.28 × 100
Ask?$271.00 × 100
Spread?$0.72
Midpoint?$270.64
Valuation & Ratios
Market Cap?644.3B
Shares Out?2.4B
Float?2.4B
Float %?100.0%
P/E Ratio?30.63
P/B Ratio?7.58
EPS?$8.73
Dividend?1.96%
Ex-Dividend?2026-08-25
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
658.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?99
Momentum?69
Short Sent.?69
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.47Safe
Confidence?74%Moderate
Short InterestLow
Short % of Float?1.06%Low
Short Interest?25.4M
Days to Cover?3.0
Free Float2.4B
Avg Daily Volume8.5M
Settlement Date2026-07-31
Financial Health
Current Ratio?1.09Adequate
Quick Ratio?0.81Weak
Cash Ratio?0.37Low
Debt/Equity?0.58Moderate
ValuationFAIRLY VALUEDvs 9 peers + S&P 500
Score56/100
P/E?30.6PRICEY▾
Peers75
S&P32
P/B?7.58FAIR▾
Peers63
S&P25
P/S?6.58FAIR▾
Peers50
S&P19
P/FCF?29.0FAIR▾
Peers50
S&P31
EV/EBITDA?19.9FAIR▾
Peers63
S&P26
EV/Sales?6.87HIGH▾
Peers50
S&P21
Returns & Efficiency
ROE?24.8%STRONG▾
Peers63
S&P74
ROA?10.5%STRONG▾
Peers75
S&P76
Cash Flow & Enterprise
FCF?$22.2B
Enterprise Value?$672.9B
Fundamentals ratios updated end of day